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Edited by Robert BaroukiAbstract Regenerating gene product (Reg) is induced in pan-
creatic b-cells and acts as an autocrine/paracrine growth factor
for regeneration via a cell surface Reg receptor. However, the
manner by which Reg induces b-cell regeneration was unknown.
In the present study, we found that Reg increased phospho-ATF-
2, which binds to 57 to 52 of the cyclin D1 gene to activate
the promoter. The Reg/ATF-2-induced cyclin D1 promoter acti-
vation was attenuated by PI(3)K inhibitors such as LY294002
and wortmannin. In Reg knockout mouse islets, the levels of
phospho-ATF-2, cyclin D1, and phospho-Rb were greatly
decreased. These results indicate that the Reg–Reg receptor
system stimulates the PI(3)K/ATF-2/cyclin D1 signaling path-
way to induce b-cell regeneration.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Knockout mouse1. Introduction
Strategies for preventing b-cell destruction and inﬂuencing
the replication and growth of the b-cell mass are important
for the prevention and/or treatment of diabetes [1,2]. We have
previously demonstrated the mechanism of b-cell damage and
its prevention [1–3], and further found an autocrine/paracrine
b-cell regeneration factor, Reg (regenerating gene) protein [4,5],
that increases the b-cell replication [6–10]. Reg is induced in
insulin-producing pancreatic b-cells by inﬂammatory stimula-
tion such as by IL-6/glucocorticoids [11] and acts as an auto-
crine/paracrine growth factor for b-cell regeneration via a
cell surface Reg receptor [12] to ameliorate experimental diabe-
tes [6–8]. Recently, we produced Reg transgenic and knockout
mice [2,8]. The islets from the transgenic mice expressing Reg
in b-cells showed increased [3H]thymidine incorporation, and
the development of diabetes in the non-obese diabetic
(NOD) mice carrying the Reg transgene was signiﬁcantly
retarded. On the other hand, the [3H]thymidine incorporation*Corresponding author. Fax: +81 22 717 8083.
E-mail address: okamotoh@mail.tains.tohoku.ac.jp (H. Okamoto).
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doi:10.1016/j.febslet.2005.12.070in the islets from Reg knockout mice was decreased, and the
islets of Reg knockout mice were signiﬁcantly smaller than
those of control wild mice when the goldthioglucose-induced
hyperplasticity of islets was compared [8]. Therefore, adequate
expression of Reg gene appears to be essential for the regener-
ation of b-cells. However, the Reg-induced intracellular signal
transduction pathway in pancreatic b-cells has been elusive.
In the present study, we found that Reg stimulates the
PI(3)K/ATF-2/cyclin D1 signaling pathway to induce b-cell
regeneration.2. Materials and methods
2.1. Antibodies and reagents
[c-32P]ATP and ECL Western Blotting Detection System were
purchased from Amersham Pharmacia Biotech, Buckinghamshire,
England. G418, DMRIE-C and pCMV-SPORT b-gal from Invitrogen,
Carlsbad, CA. PD98059 and wortmannin from Wako Pure Chemistry,
Osaka, Japan, and LY294002 and SB203580 from Sigma (St. Louis,
MO). KN-62, KN-93 and H-89 were from Seikagaku Corp., Tokyo,
Japan, and K-252a from Calbiochem (San Diego, CA). Pica Gene
Luminescence Kit was from Toyo Ink Mfg. Co., Ltd., Tokyo, Japan,
and Aurora GAL-XE from ICN, Costa Mesa, CA. pGL3-Basic vector
and pCIneo mammalian expression vector were from Promega,
Madison, WI and pFR-Luc, pFA2-cJun, pFA2-Elk1, pFA2-CREB,
pFA2-CHOP, pFA2-cFOS, pFA2-ATF2, pFC-dbd, pFC-MEKK,
pFC-MEK1, pFC-MEK3 and pFC-PKA for PathDetect analyses
from Stratagene, La Jolla, CA. PI(3)K expression vector, anti-
PI(3)K p110a antibody for immunoprecipitation, and anti-poly-
(ADP-ribose) polymerase (PARP) antibody were purchased from
Upstate Biotechnology, Lake Placid, NY. The anti-phospho-ATF-2
(Thr-71) antibody kit, anti-Rb, anti-phospho-Rb (Ser-780, Ser-795,
Ser-807/811) antibody kit, anti-SAPK/JNK, anti-p38 MAPK, and
ATF-2 fusion protein were from Cell Signaling, Beverly, MA, and
anti-cyclin D1, anti-ATF-2, anti-phospho-ATF-2 (Thr-71), anti-Sp3,
anti-PI(3)K p110a, and protein A/G PLUS agarose were from Santa
Cruz, Santa Cruz, CA. The ChIP-IT chromatin immunoprecipitation
and shearing kit was purchased from Active Motif, Carlsbad, CA.
2.2. Mice and islet culture
Mice lacking Reg were generated by homologous recombination [8].
The mice used for each experiment were derived from ICR background
and were from the same litter or the same family. All animals were
maintained in a 12-h light/12-h dark photoperiod in a humidity- and
temperature-controlled room (24 C). Water and food were available
ad libitum. The animals used in this study were treated in accordance
with the Guiding Principles for Care and Use of Research Animals
promulgated by Tohoku University Graduate School of Medicine,
Sendai, Japan. The islet culture was carried out as described [6,8].blished by Elsevier B.V. All rights reserved.
Table 1
Induction of ATF-2 dependent transcription by Rega
Relative luciferase activity (%)
No addition Reg stimulation
ATF-2 100 ± 78.0 590 ± 38.1*
CREB 100 ± 26.5 129.4 ± 14.7
cJun 100 ± 73.7 71.1 ± 10.5
Elk1 100 ± 9.23 113.8 ± 38.5
CHOP 100 ± 6.88 136.4 ± 3.12
cFos 100 ± 21.38 78.3 ± 12.15
586 S. Takasawa et al. / FEBS Letters 580 (2006) 585–591After the initial recovery period in RPMI-1640 containing 10% FCS
and 2.7 mM glucose for 24 h, islets were transferred to 96-well culture
dishes in groups of 10 islets. The islets were cultured in RPMI-1640
containing 2% FCS and 2.7 mM glucose for 48 h.
2.3. Construction of reporter genes and expression vectors
The rat cyclin D1 promoter [13] (539 to +39) was ampliﬁed by
PCR and the 578-bp fragment was subcloned into pGL3-Basic vector
(539CD1LUC). The constructions, 60CD1LUC, 60mut1C-
D1LUC, and 60mut2CD1LUC, were created by PCR from
539CD1LUC with speciﬁc primers, and the region including the
ATF-2 binding site was mutated from 5 0-AGTAACGTCACTCG-
GACTAC-3 0 to 5 0-AGTATGGTCACTCGGACTAC-3 0 (60mut1C-
D1LUC) or to 5 0-AGTAACCACACTCGGACTAC-30 (60mut2-
CD1LUC). The expression vectors encoding the wild type rat ATF-2
[14] (nucleotide residues 328–1830) and a dominant-negative mutant
of the ATF-2 encoding amino acid residues 77–487 (nucleotide resi-
dues 567–1830) were constructed in pCIneo mammalian expression
vector [15].
2.4. Cell culture and transfections
RINm5F b-cells [11,12], which were derived from a rat insulinoma,
were in RPMI1640 supplemented with 10% FCS. Forty-eight hours be-
fore transfection, 1 · 105 cells were seeded into each well of a 24-well
plate. Transfections were performed with DMRIE-C as described
[11]. After 24 h incubation at 37 C in RPMI1640 with 1% FCS, the
medium of each well was replaced with fresh medium containing
Reg (33 nM) and protein kinase inhibitors and incubated for a further
6 h. Luciferase activity was determined as described [11] using a Pica
Gene Luminescence Kit. b-Galactosidase activity was determined
using Aurora GAL-XE.
2.5. Immunoblot analyses
The whole cell or nuclear extract was subjected to SDS–polyacryl-
amide gel electrophoresis and electrotransferred to a PVDF membrane
as described [16]. Western blotting was carried out as described previ-
ously [11,12,16,17].
2.6. Reverse transcriptase-polymerase chain reaction (RT-PCR)
Total RNA was isolated and reverse-transcribed as described [11,17]
using 1 lg RNA as a template. PCR was performed on each reverse-
transcribed sample (1/20, 1 ll) for 35 and 30 cycles for cyclin D1 and
glyceraldehydes-3phosphate dehydrogenase (GAPDH), respectively.
The sequences of the primers for cyclin D1 cDNA (GenBank accession
number NM171992) ampliﬁcation were 5 0-CGCGCCCTCCGT-
TTCTTACTTCA-3 0 and 5 0-AACTTCTCGGCAGTCAGGGGA-3 0;
for GAPDH cDNA ampliﬁcation, they were as described [11].
2.7. Immunekinase assay
Forty lg of PI(3)K p110a expression vector was introduced into
RINm5F cells (8 · 106 cells) as described [17]. After 48 h, cells were
harvested in 0.2 ml of ice-cold lysis buﬀer (50 mM Tris–HCl, pH 7.5,
150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 1 tab-
let/50 ml of Complete). The lysate was incubated on ice for 1 h, fol-
lowed by centrifugation at 100000 · g for 1 h. Immunoprecipitation
was performed using either anti-PI(3)K p110a rabbit antibody or
anti-CD38 rabbit antibody [18] and Protein A/G PLUS agarose.
Immunoprecipitates were washed and subjected to in vitro ATF-2
kinase assay using ATF-2 fusion protein as a substrate. The reactions
were done in a volume of 5 ll containing 25 mM Tris–HCl (pH 7.5),
10 mM MgCl2, 0.1 mM Na3VO4, 5 mM glycerol 2-phosphate, 2 mM
DTT, and 50 ng/ll ATF-2 fusion protein at 30 C. The reaction was
terminated by the addition of SDS–polyacrylamide gel electrophoresis
sample buﬀer, run on 12.5% SDS gels, transferred to PVDF mem-
brane, and phospho-ATF-2 was detected by immunoblot analysis
using anti-phospho-ATF-2 (Thr-71) antibody.aRINm5F b-cells were cotransfected with pFA-ATF2, pFA2-CREB,
pFA2-cJun, pFA2-Elk1, pFA-CHOP, pFA-cFos, together with the
pFR-Luc reporter plasmids. Cells were also transfected with the pFC-
dbd plasmid as the vector control. Cells were stimulated with Reg
(33 nM). The results are means ± S.E. of three to six experiments.
*P < 0.02 (diﬀerent from no addition).2.8. Oligodeoxyribonucleotides and electrophoretic mobility shift assay
(EMSA)
The wild type ATF-2 site of the cyclin D1 promoter, CD1W, and its
mutants, CD1M1 and CD1M2, were synthesized as complementary
oligodeoxyribonucleotide strands for EMSA. The sequences of theindividual oligonucleotides in the sense orientation were as follows:
CD1W, 5 0-AACAACAGTAACGTCACTCGGAC-3 0 corresponding
to nucleotides 66 to 44 of rat cyclin D1 promoter; CD1M1, 5 0-
AACAACAGTATGGTCACTCGGAC-30; CD1M2, 5 0-AACAAC-
AGTAACCACACTCGGAC-3 0. EMSA was performed using nuclear
extracts as described previously [11]. Mobility shift assays were per-
formed as described [11]. When competition experiments were con-
ducted in the presence of a 100-fold molar excess of cold probe, an
unlabeled competitor was added with the labeled probe. In the super-
shift assay, 2 lg of antibody for supershift grade were added prior to
the addition of the 32P-probe.
2.9. Chromatin immunoprecipitation (ChIP) assays
ChIP assays were performed using a ChIP-IT kit (Active Motif,
Carlsbad, CA) following the manufacturer’s instructions. Unless
otherwise stated, all reagents, buﬀers, and supplies were included in
the kit. Brieﬂy, RINm5F cells were cross-linked with 1% formaldehyde
for 10 min at room temperature. After washing and treatment with
glycine Stop-Fix solution, the cells were re-suspended in lysis buﬀer
and incubated for 30 min on ice. The cells were homogenized and
nuclei were re-suspended in shearing buﬀer and subjected to optimized
ultrasonic disruption conditions to yield 100–400-bp DNA fragments.
The chromatin was precleared with protein G beads and incubated
(overnight at 4 C) with 2 lg of anti-ATF-2 (Santa Cruz). Protein G
beads were then added to the antibody/chromatin incubation mixtures
and incubated for 1.5 h at 4 C. After extensive washing, the immuno-
precipitated DNA was removed from the beads in an elution buﬀer. To
reverse cross-links and remove RNA, 5 M NaCl and RNase were
added to the samples and incubated for 4 h at 65 C. The samples then
were treated with proteinase K for 2 h at 42 C, and the DNA was
puriﬁed using gel exclusion columns. The puriﬁed DNA was subjected
to PCR ampliﬁcation (1 cycle of 95 C for 3 min, 35 cycles of 95 C for
20 s, 64 C for 20 s, and 72 C for 1 min) of the cyclin D1 promoter
using speciﬁc forward (5 0-TTCTCTGCCCGGCTTTGATCTC-3 0)
and reverse (5 0-CTCTCTGCTACTGCGCCAACA-30) primers de-
signed to amplify the promoter region (92 to +27 nucleotides in
relation to the transcription start site). The PCR products were
resolved by electrophoresis in a 2% agarose gel and visualized after
ethidium bromide staining.3. Results
3.1. Reg induced ATF-2 activation
To determine what intracellular signal transduction events
are induced in pancreatic b-cells by Reg, we tested several sig-
nal transduction pathways in pancreatic b-cells by Reg stimu-
lation using PathDetect in vivo trans-reporting systems and
found that ATF-2, but not CREB, cJun, Elk1, CHOP or cFos,
was activated by Reg stimulation (Table 1). The ATF-2 activa-
tion was also observed by the cotransfection of the Reg recep-
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ium (Fig. 1A). Phosphorylation of ATF-2 at Thr-71 was in-
creased by the stimulation of Reg (Fig. 1B). These results
indicate that the Reg–Reg receptor system activates ATF-2,
suggesting that genes under the control of ATF-2 play an
important role in the cell cycle progression in pancreatic b-
cells.
3.2. Reg-induced cyclin D1 activation through ATF-2
We investigated whether the target of ATF-2 is the cyclin D1
promoter in Reg-activated pancreatic b-cells by using a repor-
ter plasmid containing the rat cyclin D1 promoter (539 to
+39 of GenBank AF148946; -539CD1LUC) in transiently
transfected RINm5F b-cells, a rat insulinoma cell line. The cy-
clin D1 promoter activation by Reg addition to the culture
medium was induced in a dose-dependent manner (Fig. 2A)
and, in fact, the endogenous levels of cyclin D1 and cyclin
D1 mRNA were increased by Reg treatment 2 h and 30 min la-
ter, respectively (Fig. 2B). Furthermore, the cotransfection of
an ATF-2 expression vector with the cyclin D1 reporter con-
struct also increased the activity of the cyclin D1 promoter
(Fig. 2C). The addition of Reg to the medium of the cells
which had been cotransfected with ATF-2 expression plasmid
did not induce signiﬁcantly more promoter activity than the
ATF-2 cotransfection or Reg addition alone. The increases
in the cyclin D1 promoter were almost the same as the in-
creases in phospho-ATF-2 (Fig. 2C, lower panel). A deleted
promoter (60CD1LUC) containing the possible ATF-2 bind-
ing site (57 to 52) still responded to the Reg addition as well
as to the cotransfection of ATF-2 expression plasmid, but re-Fig. 1. Reg–Reg receptor signaling induces ATF-2 activation. (A)
Overexpression of Reg receptor induces ATF-2 dependent transcrip-
tion. RINm5F b-cells were cotransfected with pCIneo-Reg receptor
expression plasmid [12] together with pFA-ATF2 and pFR-Luc
plasmids. The results are means ± S.E. of three experiments. \,
P < 0.02 (diﬀerent from no addition). (B) Phosphorylation of ATF-2
at Thr-71 by Reg. RINm5F b-cell extracts were immunoblotted with a
phospho-Thr-71-speciﬁc antibody for ATF-2, followed by reprobing
with an anti-ATF-2 antibody to control for loading.porter mutants in which the ATF-2 site had been destroyed
(60mut1CD1LUC and 60mut2CD1LUC) showed no
increase of promoter activity by either the Reg addition or
the ATF-2 cotransfection (Fig. 2D). Electrophoretic mobility
shift assays were then performed with nuclear extracts from
RINm5F b-cells and 32P-labeled double-strand oligonucleotide
corresponding to the ATF-2 binding sequence of cyclin D1
promoter. As shown in Fig. 2E, Reg-stimulated RINm5F
b-cell nuclear proteins formed a speciﬁc complex with the
ATF-2 site, which could be blocked by a 100-fold excess of
unlabeled probe. Addition of the antibody against ATF-2
resulted in the formation of a supershift, suggesting the pres-
ence of ATF-2 in the complex. This was further supported
by the result that the addition of the antibody against phos-
pho-ATF-2 at Thr-71 resulted in the formation of a supershift
in the nuclear extract from Reg-stimulated RINm5F b-cells.
The ATF-2 binding to the cyclin D1 promoter in response to
Reg stimulation was further demonstrated by ChIP assay
(Fig. 2F). The essential involvement of ATF-2 activation in
the Reg-induced activation of the cyclin D1 promoter was fur-
ther conﬁrmed by the inhibition of the Reg-induced activation
of the cyclin D1 promoter with the cotransfection of the dom-
inant-negative ATF-2 expression plasmid (Fig. 2G).3.3. Involvement of the PI(3) kinase pathway in ATF-2
activation for cyclin promoter activity
To determine the intracellular signaling pathway(s) by which
Reg induced the cyclin D1 promoter activity via the ATF-2
activation, several chemical inhibitors were employed. The
addition of PI(3)K inhibitors LY294002 and wortmannin
attenuated the Reg-induced ATF-2 phosphorylation/activa-
tion (Fig. 3A). Furthermore, the addition of PI(3)K inhibitors
LY294002 and wortmannin to cells transfected with ATF-2
and the cyclin D1 promoter reporter showed attenuated
ATF-2-induced cyclin D1 promoter activity (Fig. 3B) whereas
SB203580, a p38 mitogen-activated protein (MAP) kinase
inhibitor, PD98059, an inhibitor of the MAP kinase/ERK
kinase-ERK pathway, KN-62 and KN-93, inhibitors of
Ca2+/calmodulin-dependent protein kinase (CaM kinase) II,
K-252a, an inhibitor of CaM kinase IV, and the A-kinase
inhibitor, H-89 showed a very weak (but statistically not signif-
icant) inhibitory eﬀect on the cyclin D1 promoter activity in b-
cells. In addition, overexpression of MEKK, MEK1, MEK3,
and the catalytic subunit of PKA failed to increase the cyclin
D1 promoter activity (not shown). The Reg-induced cyclin
D1 promoter activity was actually inhibited by the addition
of LY294002, whereas PD98059 scarcely reduced the activity
(Fig. 3C). These results likely indicate that an LY294002-sen-
sitive pathway involving PI(3)K mediates the signal transduc-
tion by Reg. Moreover, the immunoprecipitated PI(3)K
phosphorylated ATF-2 in a time-dependent and dose-depen-
dent fashion (Fig. 3D and E), indicating that PI(3)K directly
phosphorylates ATF-2 to activate the cyclin D1 promoter.3.4. Decreases in phospho-ATF-2, cyclin D1, and phospho-Rb in
Reg knockout islets
We produced Reg-knockout mice by homologous recombi-
nation [8]. In Reg/ mice, no Reg expression was detected
in the pancreas and therefore no Reg was secreted into the islet
culture medium [8]. We isolated pancreatic islets from Reg+/+
and Reg/ mice and compared their BrdU incorporation
Fig. 2. Activation of the cyclin D1 promoter by ATF-2. (A) Reg induced the cyclin D1 promoter in a dose-dependent manner. RINm5F b-cells
were transfected with 539CD1LUC and stimulated with increasing concentrations of Reg. The results are means ± S.E. of three experiments. (B)
Induction of cyclin D1 by Reg treatment. RINm5F b-cells were treated with Reg (+) or without Reg () at 33 nM Reg. Cells were harvested at
the indicated time after the stimulation. Upper panel shows immunoblot analysis of cyclin D1. Middle and lower panels show RT-PCR analyses
of cyclin D1 and GAPDH, respectively. (C) Reg and ATF-2 induced the cyclin D1 promoter. RINm5F b-cells were transfected with
539CD1LUC and ATF-2 expression plasmid or with 539CD1LUC alone, and stimulated with Reg. The results are means ± S.E. of three to
ﬁve experiments. \, P < 0.01 (diﬀerent from no addition). NS, not signiﬁcant. Phosphorylation status of ATF-2 by immunoblotting is also shown
in the lower panel. Reg (33 nM) and anti-Reg monoclonal antibody (aReg; 5 lg/ml) [11] were added in the culture medium. Phosphorylation of
ATF-2 by the addition of Reg was attenuated by the addition of anti-Reg monoclonal antibody, and Reg receptor overexpression without the
addition of Reg increased the phosphorylation of ATF-2. (D) Localization of the ATF-2-dependent cyclin D1 promoter. RINm5F b-cells were
cotransfected with reporter plasmids (60CD1LUC, 60mut1CD1LUC or 60mut2CD1LUC) together with the ATF-2 expression plasmid. Cells
were also transfected with either reporter plasmid alone and then stimulated with Reg. The results are the means ± S.E. of three to six
experiments. \, P < 0.01 (diﬀerent from no addition). (E) ATF-2 binds to the cyclin D1 promoter. Nuclear extracts from RINm5F b-cells were
incubated with 32P-labeled cyclin D1 promoter DNA. Nuclear extracts from Reg-treated cells were applied onto lanes 1, 3, 5, 7, 9, 11, and 13;
those from untreated cells were applied onto lanes 2, 4, 6, 8, 10, 12, and 14. (F) ChIP assay showing Reg increases in ATF-2 binding to the cyclin
D1 promoter. Nuclear proteins bound to genomic DNA in RINm5F cells were cross-linked and subjected to a ChIP assay using an antibody
against ATF-2, and oligonucleotide primers to PCR amplify the cyclin D1 promoter. (G) ATF-2 activity is necessary for the activation of the
cyclin D1 promoter by Reg. RINm5F b-cells were cotransfected with the 539CD1LUC reporter and either an empty expression vector or an
expression vector for dominant-negative ATF-2 (DN). Cells were then stimulated with Reg (33 nM). The results are means ± S.E. of three to ﬁve
experiments. \, P < 0.01 (diﬀerent from no addition).
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Fig. 3. Involvement of the PI(3)K pathway in ATF-2 activation for cyclin D1 promoter activity. The results of treatment with the MAP kinase/ERK
kinase inhibitor PD98059 (10 lM), the PI(3)K inhibitors LY294002 (50 nM) and wortmannin (100 nM), the p38 MAP kinase inhibitor SB203580
(10 lM), the CaM kinase II inhibitors KN-62 (10 lM) and KN-93 (10 lM), the CaM kinase IV inhibitor K-252a (1 lM) and the A-kinase inhibitor
H-89 (10 lM) were compared with that of DMSO vehicle treatment. (A) Attenuation of Reg-induced ATF activation by PI(3)K inhibitors. RINm5F
b-cells were cotransfected with pFA-ATF2 and the pFR-Luc reporter plasmids. Cells were stimulated with Reg (33 nM). The results are means ± S.E.
of three to six experiments. \, P < 0.03 (signiﬁcantly decreased from the Reg activated promoter activity). The phosphorylation status of endogenous
ATF-2 is also shown in the lower panel. The inhibitory eﬀects of PD98059, KN62, KN93, and H89 were not statistically signiﬁcant. (B) Attenuation
of ATF-2-induced cyclin D1 promoter activity by PI(3)K inhibitors. RINm5F b-cells were cotransfected with 539CD1LUC reporter and ATF-2
expression vector. Protein kinase inhibitors were added to the culture medium. The results are means ± S.E. of three to ﬁve experiments. \, P < 0.01
(signiﬁcantly decreased from the ATF-2 activated promoter activity). The inhibitory eﬀects of PD98059, KN62, KN93, and H89 were not statistically
signiﬁcant. (C) Attenuation of Reg-induced cyclin D1 promoter activity by LY294002. RINm5F b-cells were stimulated by Reg. The results are
means ± S.E. of three experiments. \, P < 0.05 (diﬀerent from no addition). LY, LY294002. PD, PD98059. (D) Time-dependent phosphorylation of
ATF-2 by immunoprecipitated PI(3)K. (E) Dose-dependent phosphorylation of ATF-2 by immunoprecipitated PI(3)K. Lanes 1 and 5, 0 ll; lanes 2
and 6, 1 ll; lanes 3 and 7, 2 ll; lanes 4 and 8, 4 ll of immunoprecipitates were used. Neither stress-activated protein kinase (SAPK)/cJun amino
terminal kinase (JNK) nor p38 MAP kinase (MAPK) was detected in the immunoprecipitate by anti-PI(3)K p110.
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without the addition of Reg in the culture medium was re-
duced compared to that in Reg+/+ islets (data not shown).
We then compared the levels of phospho-ATF-2, cyclin D1
protein, and phospho-Rb in homozygous Reg-deﬁcient mouse
islets with those in normal littermates to determine whether
Reg induces the cyclin D1 gene for the cell cycle progression
via the activation of PI(3)K/ATF-2 in Reg+/+ and Reg/
mouse islets (Fig. 4). Reg+/+ islets secreted Reg in the culture
medium and the phospho-Rb level in the islets was muchhigher than that in Reg/ islets. As expected, both the levels
of phospho-ATF-2 and cyclin D1 were decreased in islets from
Reg/ mice, whereas the levels of other proteins such as
PARP [2,11] and CD38 [2,18] as controls were unchanged.4. Discussion
The cyclin D1 gene encodes a regulatory subunit of a serine/
threonine kinase that phosphorylates and inactivates the
Fig. 4. Decreases in phospho-ATF-2, cyclin D1, and phospho-Rb in
Reg-deﬁcient islets. Islets were cultured without the addition of Reg.
Total protein from islets isolated from Reg+/+ or Reg/ mice (20 lg)
were analyzed by Western blot. Reg expression in culture medium
(10 ll) was also analyzed.
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tered transcription factors essential for the G1–S progression
of the cell cycle [19–21]. An abundance of cyclin D1 has been
shown to have a rate limiting eﬀect on the cellular proliferation
induced by diverse signaling pathways in a variety of mamma-
lian cells [19–21]. The cyclin D1 gene expression appears to be
essentially regulated at the transcription level and the
transcriptional activation occurs in a cell type- and mitotic
stimulation-speciﬁc manner [15,22,23]. Our results show con-
clusively that the activation of the cyclin D1 gene promoter
in response to Reg stimulation is mediated by the PI(3)K/
ATF-2 signal transduction pathway in pancreatic b-cells. The
growth of pancreatic b-cells is determined by the number of
b-cells entering the cell cycle rather than by changes in the rate
of the cycle [1,2,4,8,24,25]. Reg, an autocrine/paracrine pancre-
atic b-cell regeneration factor, appears to stimulate the cell
cycle progression [6–12]. Progression from the G1 to S phase
of the cell cycle requires the activation of cyclin-dependent
kinase (CDK) 4, and the CDK4 activation is controlled by
the complex formation with its catalytic partner, cyclin D1.
The expression of the cyclin D1 is controlled largely and per-
haps entirely by extracellular signals. Reg activated the cyclin
D1 promoter (Fig. 2) for the cell cycle progression, and ATF-2
is an essential transcription factor in the process of Reg-in-
duced cyclin D1 promoter activation (Figs. 1 and 2). Reg
receptor overexpression also activated ATF-2 and cyclin D1
promoter in a ligand-independent fashion (Figs. 1B and 2C),
suggesting that oligomerization of Reg receptor can activate
intracellular signaling events like Sky, MET, and CD30 recep-
tors [26–28]. The PI(3)K activation is involved in the ATF-2activation for cyclin D1 expression (Fig. 3). It has been re-
ported that disruption of the CDK4 gene resulted in the devel-
opment of insulin-deﬁcient diabetes due to a reduction in the
number of pancreatic b-cells, and that the expression of a mu-
tant CDK4, which escaped from the inhibitory regulation of
CDK4, caused islets to become hyperplastic [29]. The results
of the CDK4 disruption well explain our results that the islets
from the Reg/ mice showed reduced BrdU incorporation
(Fig. 4A), and that the islet hyperplasia induced by the gold-
thioglucose treatment was attenuated by Reg gene disruption
[8] because Reg induces a regulatory subunit of CDK4, cyclin
D1, for the cell cycle progression. Reg was also reported to
work as a growth factor for Schwann cells [30], motorneurons
[31] and gastrointestinal epithelium [32,33], and cyclin D1 was
suggested to be a key molecule for the regenerative growth of
Schwann cells [34,35]. Therefore, the signal transduction mech-
anism in the Reg-induced regenerative growth of other tissues
including Schwann cells may be the same as that of pancreatic
b-cells. Further studies on tissue regeneration other than that
of pancreatic b-cells using Reg/ mice are in progress in our
laboratory.
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